Fox Chase Cancer Center News

PHILADELPHIA (June 21, 2021)—Researchers at Fox Chase Cancer Center have identified Musashi-2 (MSI2) protein as having the potential to both identify targeted therapies for certain patients with non-small cell lung cancer (NSCLC) and to serve as a target for the development of new therapies.

PHILADELPHIA (June 21, 2021)—Elizabeth Plimack, MD, MS, chief of the Division of Genitourinary Medical Oncology and professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, was recently appointed medical oncology editor for the journal European Urology.

PHILADELPHIA (June 18, 2021)—Three researchers from the Fox Chase Cancer Prevention and Control Program were recognized by Temple University with the Social & Behavioral Sciences Community Partner Outstanding Supervisor Award. This year’s honorees were Jennifer Barsky Reese, PhD; Linda Fleisher, PhD, MPH; and Suzanne M. Miller, PhD.

PHILADELPHIA (June 18, 2021)–Researchers at Fox Chase Cancer Center are using a powerful single nucleotide polymorphism-based chromosome microarray (CMA) to differentiate between benign and cancerous lipomatous tumors.

PHILADELPHIA (June 18, 2021)—A study from researchers at Fox Chase Cancer Center suggests that some breast cancer patients may be able to forgo certain testing procedures after neoadjuvant chemotherapy, which is chemotherapy given before other treatment, without increasing their risk of cancer returning.

PHILADELPHIA (June 18, 2021)—Fox Chase Cancer Center’s main, Buckingham, and East Norriton campuses have been awarded a three-year term of reaccreditation in radiation oncology as the result of a recent review by the American College of Radiology (ACR).

PHILADELPHIA (June 15, 2021) – Researchers at Fox Chase Cancer Center recently used RNA next-generation sequencing of a fine-needle aspiration (FNA) sample to identify a novel fusion gene indicative of pleomorphic adenoma (PA), a common benign salivary gland tumor.

PHILADELPHIA (June 9, 2021)—A 70-year-old woman with Hodgkin Lymphoma being treated at Fox Chase Cancer Center had increased FDG uptake in her lymph nodes two days after receiving a COVID-19 vaccination. FDG is short for fluorodeoxyglucose, a radiolabeled sugar used during positron emission tomography (PET) scans.